MD654Z - Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III - Google Patents

Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III

Info

Publication number
MD654Z
MD654Z MDS20120167A MDS20120167A MD654Z MD 654 Z MD654 Z MD 654Z MD S20120167 A MDS20120167 A MD S20120167A MD S20120167 A MDS20120167 A MD S20120167A MD 654 Z MD654 Z MD 654Z
Authority
MD
Moldova
Prior art keywords
course
malignant melanoma
predicting
iii stage
tct
Prior art date
Application number
MDS20120167A
Other languages
English (en)
Russian (ru)
Inventor
Валериу ПАЛАДЕ
Константин ЖУКОВСКИЙ
Виктор ЧЕРНАТ
Георге ЦЫБЫРНЭ
Юлиан ЦУРКАНУ
Original Assignee
Валериу ПАЛАДЕ
Константин ЖУКОВСКИЙ
Виктор ЧЕРНАТ
Георге ЦЫБЫРНЭ
Юлиан ЦУРКАНУ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Валериу ПАЛАДЕ, Константин ЖУКОВСКИЙ, Виктор ЧЕРНАТ, Георге ЦЫБЫРНЭ, Юлиан ЦУРКАНУ filed Critical Валериу ПАЛАДЕ
Priority to MDS20120167A priority Critical patent/MD654Z/ro
Publication of MD654Y publication Critical patent/MD654Y/ro
Publication of MD654Z publication Critical patent/MD654Z/ro

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Invenţia se referă la medicină, în special la oncologie şi poate fi utilizată pentru pronosticarea evoluţiei melanomului malign de stadiul II şi III.Conform invenţiei, metoda revendicată include examenul clinic şi paraclinic, unde se stabilesc următorii parametri: concretizarea stadiului bolii (ST), prezenţa ulceraţiei (U), tipul celular al tumorii (TCT), nivelul de invazie după Clark (NI), grosimea tumorii după Breslow (GT); metoda de tratament aplicată (MT) şi sexul pacientului (SP), apoi se calculează funcţia discriminantă (F) conform formulei:F= -6,345 + 1,386 × ST + 4,768 × MT - 2,596 × SP - 3,384 × U + 0,806 × TCT + 1,780 × NI - 1,136 × GT.În cazul în care F < 0 se pronostichează o evoluţie favorabilă a melanomului malign, iar când F > 0 - o evoluţie nefavorabilă.
MDS20120167A 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III MD654Z (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20120167A MD654Z (ro) 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20120167A MD654Z (ro) 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III

Publications (2)

Publication Number Publication Date
MD654Y MD654Y (ro) 2013-07-31
MD654Z true MD654Z (ro) 2014-02-28

Family

ID=48875337

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20120167A MD654Z (ro) 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III

Country Status (1)

Country Link
MD (1) MD654Z (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD726Z (ro) * 2013-07-23 2014-08-31 Адриан КИШКА Metodă de pronostic al evoluţiei stărilor precanceroase gastrice la bărbaţi

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD239Z (ro) * 2010-02-15 2011-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de pronosticare a evoluţiei clinice a cancerului glandei mamare stadiul I
  • 2012

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD239Z (ro) * 2010-02-15 2011-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de pronosticare a evoluţiei clinice a cancerului glandei mamare stadiul I

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Balch C. M., Buzaid A. C., Soong S. J., et al. Final version of the American Joint Committee on Cancer stagind system for cutaneous melanoma. J. Clin. Oncol., 2001, vol. 19, p. 3635-3648 *
Montanara S., Luaschi A., Fideli P. et al. Malignat melanoma: analysis of survey, Ann. Oncol., 2005, 15(2S), p. 81-83 *

Also Published As

Publication number Publication date
MD654Y (ro) 2013-07-31

Similar Documents

Publication Publication Date Title
WO2014205555A8 (en) Methods and uses for diagnosis and treatment of prostate cancer
EA036698B9 (ru) Моноклональное антитело против lif человека и его применение для лечения рака с высоким уровнем lif
IN2012DN03799A (ro)
WO2010091049A3 (en) Diagnosis and treatment of cancer
TN2012000369A1 (en) 5-alkynyl-pyrimidines
EP4356960A3 (en) Biomarkers and methods of treating pd-1 and pd-l1 related conditions
EP4303584A3 (en) Methods for detecting signatures of disease or conditions in bodily fluids
WO2012068383A3 (en) ncRNA AND USES THEREOF
MX2011006555A (es) Compuestos de tiazolopiridina moduladores de sirtuina.
MX2010005186A (es) Tiazolopiridinas solubilizadas.
MX2012006822A (es) 1,7-diazacarbazoles y metodos de uso.
MX2010006039A (es) Compuestos antagonistas del acido ribonucleico para la modulacion de la expresion de la fosfoinositida-3-cinasa catalitica.
TN2011000455A1 (en) Pharmaceutical combinations comprising rdea119/bay 869766 for the treatment of specific cancers
MX2010009488A (es) Métodos para modular la actividad del receptor de mc5, y tratamiento de las afecciones relacionadas con este receptor.
WO2010129665A3 (en) Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
UA107349C2 (en) Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug
WO2013106766A3 (en) THERAPEUTIC INDICATIONS OF miR-1291
EA201390530A1 (ru) Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями
MD654Z (ro) Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III
Mitra MicroRNA therapeutics in triple negative breast cancer
UA106884C2 (uk) Похідні імідазолідин-2,4-діону та їх застосування як медикаменту
EA201490201A1 (ru) Выявление экспрессии гена prame при раковом заболевании
CR20110438A (es) Icam 1 soluble como biomarcador para predicción de respuesta terapéutica
MD3996C2 (ro) Percloraţi de 5-R-saliciliden-4-feniltiosemicarbazonato(1-)-aquacupru(II) ce posedă proprietăţi de inhibitori ai activităţii enzimei 17 b-HSD (tipul 1)
WO2012129517A3 (en) Evaluating protein expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer

Legal Events

Date Code Title Description
FG9Y Short term patent issued
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)
MM4Y Short-term patent definitely lapsed due to non-payment of fees